Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  UnitedHealth Group    UNH

UNITEDHEALTH GROUP

(UNH)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

UnitedHealth : boosts earnings forecast, set to pass price discounts to patients

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/18/2019 | 11:16am EDT
FILE PHOTO: Locomotives at Union PacificÕs Engelwood wait to return to service near downtown Houston

(Reuters) - UnitedHealth Group Inc will stick with its decision to pass on drug maker discounts to patients to help them beat rising medicine prices despite the U.S. government having withdrawn a similar proposed policy in its health programs, its top executive said on Thursday.

"You can expect us not to change our stance on rebates," Chief Executive Officer David Wichmann said on a conference call with analysts to discuss the earnings.

UnitedHealth shares were down $5.65, or 2%, at $260.94 in morning trading, after earlier rising about 1% in premarket trading on news the company beat estimates for quarterly profit and boosted its forecast for 2019 earnings.

The share decline came after the conference call, in which the company said 2019 revenue would not hit the company's original target.

"We think UnitedHealth is underperforming the peers today likely because on the call, they guided 2019 revenues to now be 'at or slightly below' the prior revenue guidance range of $243-245 billion," Scott Fidel an analyst at Stephens said.

Two analysts and one investor said the decision to stick with its point-of-sale rebates did not seem to be linked to the share price fall.

UnitedHealth said in March its pharmacy-benefit management unit OptumRx would only sell new health plans that give the after-market discounts it negotiates with drugmakers directly to patients. About 9 million of its customers are in such plans this year.The company is the first U.S. health insurer to report quarterly results after the Trump administration last week shelved its proposal to pass billions of dollars in rebates to Medicare patients.

Pharmacy benefits managers receive after-market discounts from drug companies and allow their clients, such as large employers, to incorporate them into overall premium pricing or share them with patients.

Wichmann said the government's decision showed that the Trump administration values pharmacy benefit managers as a "counterbalance" to drug prices.

UnitedHealth and other insurers still face other potential health policy changes and pressure as rising healthcare costs take the center stage in debates ahead of the 2020 U.S. presidential elections.

Some Democratic candidates have proposed a complete ban on private health insurance in favor of a government-run Medicare-for-all plan.

REVENUE OUTLOOK LOWERED

UnitedHealth Chief Financial Officer John Rex said he expects 2019 revenue to be "at or just slightly below" its previously given range of $243 billion to $245 billion in 2019.

UnitedHealth raised its full-year adjusted earnings forecast to between $14.70 and $14.90 per share, from an earlier forecast of between $14.50 and $14.75 per share.

The company's medical care ratio, or the percentage of premiums paid out for medical services, worsened to 83.1%, from 81.9% a year earlier. Analysts had expected 83%.

Net earnings attributable to shareholders rose 12.7% to $3.29 billion, or $3.42 per share, in the three months ended June 30.

Excluding items, UnitedHealth earned $3.60 per share, beating the average analyst estimate of $3.45, according to IBES data from Refinitiv.

(Reporting by Caroline Humer in New York and Tamara Mathias and Manojna Maddipatla in Bengaluru; Editing by Sriraj Kalluvila and Bernadette Baum)

By Tamara Mathias and Caroline Humer

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on UNITEDHEALTH GROUP
08/14UNITEDHEALTH GROUP : Board Authorizes Payment of Quarterly Dividend to Sharehold..
BU
08/12UNITEDHEALTH : Confronting the High Cost of Hospital Prices
PU
08/08UNITEDHEALTHCARE : to Continue to Serve Louisianans Enrolled in Medicaid
BU
08/07UNITEDHEALTH : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
07/31UNITEDHEALTH : Health Insurers Walk Delicate Line Against Democrats' Health Prop..
DJ
07/30UNITEDHEALTHCARE : Awarding $1.1 Million to Northeast Ohio Nonprofits to Help Ad..
BU
07/292019 Global Financial Services Market Research Reports & Industry Analysis
AQ
07/25UNITEDHEALTH GROUP INC : Other Events, Financial Statements and Exhibits (form 8..
AQ
07/24AM BEST : Assigns Issue Credit Rating to UnitedHealth Group Incorporated's Senio..
BU
07/24Anthem shares sink as cost concerns overshadow earnings beat
RE
More news
Financials (USD)
Sales 2019 243 B
EBIT 2019 19 347 M
Net income 2019 13 587 M
Debt 2019 24 505 M
Yield 2019 1,69%
P/E ratio 2019 17,4x
P/E ratio 2020 15,5x
EV / Sales2019 1,06x
EV / Sales2020 0,97x
Capitalization 233 B
Chart UNITEDHEALTH GROUP
Duration : Period :
UnitedHealth Group Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends UNITEDHEALTH GROUP
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Average target price 296,08  $
Last Close Price 245,69  $
Spread / Highest target 34,3%
Spread / Average Target 20,5%
Spread / Lowest Target 7,45%
EPS Revisions
Managers
NameTitle
David Scott Wichmann Chief Executive Officer & Director
Stephen J. Hemsley Executive Chairman
John Franklin Rex Chief Financial Officer
Richard J. Migliori Chief Medical Officer & EVP-Medical Affairs
Richard T. Burke Non-Executive Chairman
Sector and Competitors
1st jan.Capitalization (M$)
UNITEDHEALTH GROUP-1.38%231 471
ANTHEM INC4.92%70 122
CIGNA CORP-15.91%60 304
HUMANA1.60%39 319
CENTENE CORPORATION-16.72%19 671
WELLCARE HEALTH PLANS15.47%13 716